Evidence map›Paper›PMID 30642949›Full record

ArticleMolecular and cellular biology2019

Reevaluation of the Role of Extracellular Signal-Regulated Kinase 3 in Perinatal Survival and Postnatal Growth Using New Genetically Engineered Mouse Models.

Mathilde Soulez, Marc K Saba-El-Leil, Benjamin Turgeon, Simon Mathien, Philippe Coulombe, Sonia Klinger, Justine Rousseau, Kim Lévesque, Sylvain Meloche

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular and cellular biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mathilde Soulez *Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Quebec, Canada.
Marc K Saba-El-Leil *Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Quebec, Canada.
Benjamin TurgeonInstitute for Research in Immunology and Cancer, Université de Montréal, Montreal, Quebec, Canada.
Simon MathienInstitute for Research in Immunology and Cancer, Université de Montréal, Montreal, Quebec, Canada.
Philippe CoulombeInstitute for Research in Immunology and Cancer, Université de Montréal, Montreal, Quebec, Canada.
Sonia KlingerInstitute for Research in Immunology and Cancer, Université de Montréal, Montreal, Quebec, Canada.
Justine RousseauInstitute for Research in Immunology and Cancer, Université de Montréal, Montreal, Quebec, Canada.
Kim LévesqueInstitute for Research in Immunology and Cancer, Université de Montréal, Montreal, Quebec, Canada.
Sylvain MelocheInstitute for Research in Immunology and Cancer, Université de Montréal, Montreal, Quebec, Canada sylvain.meloche@umontreal.ca.
Institute for Research in Immunology and Cancer · CAUniversité de Montréal · CA

Funding

CIHR
6 · The paper itself

Abstract

The physiological functions of the atypical mitogen-activated protein kinase extracellular signal-regulated kinase 3 (ERK3) remain poorly characterized. Previous analysis of mice with a targeted insertion of the

Indexed as

AnimalsDisease Models, AnimalEmbryo, MammalianIntracellular Signaling Peptides and ProteinsMAP Kinase Signaling SystemMiceMitogen-Activated Protein Kinase 6Protein Serine-Threonine KinasesIntracellular Signaling Peptides and ProteinsMapk6 protein, mouseMitogen-Activated Protein Kinase 6Protein Serine-Threonine KinasesERK3MAP kinasesmouse modelsprotein kinasessignal transduction

Identifiers

PMID30642949
PMCPMC6399666
OpenAlexW2919753789

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.